HOME Research Insight New Product Launches and Capacity Expansion are the Key Growth Strategies in the Pharmaceutical Membrane Filtration Market



New Product Launches and Capacity Expansion are the Key Growth Strategies in the Pharmaceutical Membrane Filtration Market


Membrane filtration is an important separation technique in the pharmaceutical and biotechnology industries. It finds widespread applications in the biopharmaceutical industry as biopharmaceutical products and their intermediates are susceptible to degradation due to heat and chemical treatment, and are difficult to separate using other technologies. Membrane filtration has been used in pharmaceutical industry since 1935 and is presently one of the most widely adopted separation techniques in this industry.

Like all other process equipment in the pharmaceutical industry, membrane filtration products approved for use in the pharmaceutical industry have high quality standards. Further, there is a high degree of consolidation in the membrane filtration market with few large players dominating the entire market. Stringent regulatory requirements and high degree of consolidation are important entry barriers for new entrants in this market. Small and mid-size players have a small share of the market and their business interests remain concentrated in local markets across emerging geographies.

Merck Millipore (U.S.), Pall Corporation (U.S.), and Sartorius Stedim Biotech (France) are the market leaders in the pharmaceutical membrane filtration market. These companies have business interests across major geographies with Europe accounting for the largest share of their combined revenues, followed by North America.

New product launches and capacity expansion are the key growth strategies adopted by major players in the pharmaceutical membrane filtration market. The strategy of new product launches was mainly adopted by Merck Millipore (U.S.), Pall Corporation (U.S.), and Sartorius Stedim Biotech (France). Capacity expansion strategy was mainly adopted by Novasep (France), Pall Corporation (U.S.), and Sartorius Stedim Biotech (France). Companies adopted these strategies in order to expand their product portfolio and strengthen their market presence.

Related Reports:

Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) - Trends & Forecast to 2018

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports